List of works - Stanislav Sitkin

A proposed treatment algorithm for mild to moderate ulcerative colitis-with an emphasis on budesonide foam and mucosal healing

scientific article published on 03 April 2018

All-Russian Consensus on Diagnosis and Treatment of Celiac Disease in Children and Adults

scientific article

Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD?

scientific article published on 09 July 2018

Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease

scientific article published on 01 November 2019

Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same

scientific article published on 16 October 2020

COLON DYSBACTERIOSIS (DYSBIOSIS): MODERN STATE OF THE PROBLEM, COMPREHENSIVE DIAGNOSIS AND TREATMENT CORRECTION

scientific article

Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Disease

scientific article published on 01 March 2019

Complete Genome Sequences of the Probiotic Lactic Acid Bacteria Lactobacillus helveticus D75 and D76.

scientific article published on 15 March 2018

EFFECT OF CARBOXYLIC ACIDS OF GUT MICROBIAL ORIGIN ON HOST CELL PROLIFERATION IN ORGANOTYPIC TISSUE CULTURES

article published in 2016

FUNCTIONAL FOODS ARE CRITICAL COMPONENTS OF TREATMENT OF METABOLIC DISORDERS IN CELIAC DISEASE

GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CELIAC DISEASE

scientific article published on 01 January 2015

Gut Microbiota as a Host Defender and a Foe: The 2 Faces of Commensal Bacteroides thetaiotaomicron in Inflammatory Bowel Disease

scientific article published on 01 May 2019

How to Increase the Butyrate-producing Capacity of the Gut Microbiome: Do IBD Patients Really Need Butyrate Replacement and Butyrogenic Therapy?

scientific article published on 01 June 2018

IDENTIFICATION OF BACTERIOCIN GENES IN PROBIOTIC STRAINS OF LACTIC ACID BACTERIA LACTOBACLLUS ACIDOPHILUS D-75 AND LACTOBACILLUS ACIDOPHILUS D-76

Low-molecular-weight components of the metabolome control the proliferative activity in cellular and bacterial cultures.

scientific article

METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS

article published in 2016

Metabolomic Biomarkers in Gynecology: a Treasure Path or a False Path?

scientific article published on 04 January 2019

NUTRITIONAL FACTORS OF ANEMIA IN ULCERATIVE COLITIS PATIENTS

scientific article published in January 2016

Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes

scientific article published on 22 November 2020

Whole-Genome Sequencing of Lactobacillus helveticus D75 and D76 Confirms Safety and Probiotic Potential

scientific article published on 26 February 2020

[Diet therapy for irritable bowel syndrome]

scientific article published on 03 September 2020

List of works by Stanislav Sitkin

A proposed treatment algorithm for mild to moderate ulcerative colitis-with an emphasis on budesonide foam and mucosal healing

All-Russian Consensus on Diagnosis and Treatment of Celiac Disease in Children and Adults

Alterations in Polyunsaturated Fatty Acid Metabolism and Reduced Serum Eicosadienoic Acid Level in Ulcerative Colitis: Is There a Place for Metabolomic Fatty Acid Biomarkers in IBD?

Altered Sphingolipid Metabolism and its Interaction With the Intestinal Microbiome Is Another Key to the Pathogenesis of Inflammatory Bowel Disease

Bad "Good" Bile Acids and Gut Microbiota Dysbiosis in Inflammatory Bowel Disease: Mice and Humans Are Not the Same

COLON DYSBACTERIOSIS (DYSBIOSIS): MODERN STATE OF THE PROBLEM, COMPREHENSIVE DIAGNOSIS AND TREATMENT CORRECTION

Clinical Potential of Anti-inflammatory Effects of Faecalibacterium prausnitzii and Butyrate in Inflammatory Bowel Disease

Complete Genome Sequences of the Probiotic Lactic Acid Bacteria Lactobacillus helveticus D75 and D76.

EFFECT OF CARBOXYLIC ACIDS OF GUT MICROBIAL ORIGIN ON HOST CELL PROLIFERATION IN ORGANOTYPIC TISSUE CULTURES

FUNCTIONAL FOODS ARE CRITICAL COMPONENTS OF TREATMENT OF METABOLIC DISORDERS IN CELIAC DISEASE

GUIDELINES FOR DIAGNOSIS AND TREATMENT OF CELIAC DISEASE

Gut Microbiota as a Host Defender and a Foe: The 2 Faces of Commensal Bacteroides thetaiotaomicron in Inflammatory Bowel Disease

How to Increase the Butyrate-producing Capacity of the Gut Microbiome: Do IBD Patients Really Need Butyrate Replacement and Butyrogenic Therapy?

IDENTIFICATION OF BACTERIOCIN GENES IN PROBIOTIC STRAINS OF LACTIC ACID BACTERIA LACTOBACLLUS ACIDOPHILUS D-75 AND LACTOBACILLUS ACIDOPHILUS D-76

Low-molecular-weight components of the metabolome control the proliferative activity in cellular and bacterial cultures.

METABOLIC DYSBIOSIS OF THE GUT MICROBIOTA AND ITS BIOMARKERS

Metabolomic Biomarkers in Gynecology: a Treasure Path or a False Path?

NUTRITIONAL FACTORS OF ANEMIA IN ULCERATIVE COLITIS PATIENTS

Oral butyrate modulates the gut microbiota in patients with inflammatory bowel disease, most likely by reversing proinflammatory metabolic reprogramming of colonocytes

Whole-Genome Sequencing of Lactobacillus helveticus D75 and D76 Confirms Safety and Probiotic Potential

[Diet therapy for irritable bowel syndrome]

[FEATURES OF FUNCTIONAL DISORDERS GASTRODUODENOBILIARY SYSTEM IN PATIENTS WITH CELIAC DISEASE]